Bloomberg
Mine nyheder

Vi har ikke publiceret nogle artikler for nyligt i de emner, du følger. Søg efter andre emner her.

Du har ingen overvågninger endnu

Klik på ikonet for at overvåge
emner og journalister.

Cost to develop a drug more than doubles to $2.56 billion

Drug and biotechnology companies have come under pressure from lawmakers and health insurance companies to justify the costs of of their products. Foto: Jacob Ehrbahn

WASHINGTON - It costs drugmakers $2.56 billion to bring a new medicine to market, on average, more than double the price of 11 years ago, according to a study released Tuesday.

The higher cost comes from clinical trials that are larger and more complex, as well as more drugs that fail in development, according to the researchers. While the Food and Drug Administration is sometimes blamed for driving up costs because of the time it takes to review new drugs, that wasn't a factor, according to the study by the Tufts Center for the Study of Drug Development...

Læs også
Top job